Evaluation of resistance index of several anticancer agents on parental and resistant P-388 cell lines

Carulli, 1990, Multidrug resistance: focus in hematology, Haematologica, 75, 363 Beck, 1990, Multidrug resistance and its circumvention, Eur. J. Cancer, 26, 513, 10.1016/0277-5379(90)90028-R Petrini, 1993, Activity of different revertant agents on multidrug resistance: in vitro evaluation of their combination, Int. J. Tiss. React., 15, 17 Carulli, 1990, Nicardipin as chemosensitizing agent in two P-glycoprotein positive leukemia patients, Haematologica, 75, 300 Dalton, 1990, Drug resistance in multiple myeloma and non Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy, J. clin. Oncol., 7, 415, 10.1200/JCO.1989.7.4.415 Bessho, 1985, Treatment of children with refractory acute lymphocytic leukemia with vincristine and diltiazem, Med. Ped. Oncol., 13, 199, 10.1002/mpo.2950130408 Ozols, 1987, Verapamil and adriamycin in the treatment of drug resistant ovarian cancer patients, J. clin. Oncol., 5, 641, 10.1200/JCO.1987.5.4.641 Coley, 1990, 9-Alkyl, Morpholinyl anthracyclines in the circumvention of multidrug resistance, Eur. J. Cancer, 26, 665, 10.1016/0277-5379(90)90112-7 De Vries, 1990, Morpholinyl anthracycline: option for reversal of anthracycline resistance, Eur. J. Cancer, 26, 659, 10.1016/0277-5379(90)90110-F Berman, 1991, Results of a randomized trial comparing iadarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia, Blood, 77, 1666, 10.1182/blood.V77.8.1666.1666 Wiernik, 1992, Cytarabine plus idarubicin or daunorubicin as induction therapy and consolidation therapy for previously untreated adult patients with acute myeloid leukemia, Blood, 79, 313, 10.1182/blood.V79.2.313.313 Berman, 1991, Comparative cellular pharmacology of daunorubicin and idarubicin in human multidrug-resistant leukemia cells, Blood, 79, 3267, 10.1182/blood.V79.12.3267.3267 Scheper, 1988, Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multidrug resistance, Int. J. Cancer, 42, 389, 10.1002/ijc.2910420314 Kartner, 1985, Detection of P-glycoprotein in multidrug resistant cell lines by monoclonal antibodies, Nature, 316, 820, 10.1038/316820a0 Petrini, 1993, Idarubicin is active on MDR cells: evaluation of DNA synthesis inhibition on P-388 cell lines, Ann. Hemat., 67, 227, 10.1007/BF01715052 Liu, 1991, Mitoxantrone and cytosine arabinoside as first line therapy in elderly patients with acute myeloid leukemia, Br. J. Haemat., 79, 415, 10.1111/j.1365-2141.1991.tb08049.x Prentice, 1983, Sequential studies on the role of mitoxantrone in the treatment of acute leukemia, Cancer Treat. Rev., 10, 57, 10.1016/0305-7372(83)90024-5 Estey, 1983, Phase II trial of mitoxantrone in refractory acute leukemia, Cancer Treat. Rep., 67, 389 Paietta, 1994, Significantly lower P-glycoprotein expression in acute promyelocytic leukemia than in other types of acute myeloid leukemia: immunological, molecular and functional analyses, Leukemia, 8, 968 Grandi, 1988, Screening of anthracycline analogs, Vol. 6, 571 Schott, 1989, Comparative cytotoxicity, DNA synthesis inhibition and drug incorporation of eight anthracyclines in a model of doxorubicin sensitive and resistant rat glyoblastoma cells, Biochem. Pharmac., 38, 167, 10.1016/0006-2952(89)90164-0